Oxaliplatin: all 947 studies that test it
Page 8 of 10. Open to participants first (145), then studies with results posted, then the rest; newest registration first within each.
- Irinotecan/Oxaliplatin/5-Fluorouracil/Leucovorin/Cetuximab As First Line Treatment In Colorectal CancerCompletedNCT00689624Phase 2
- Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal CancerCompletedNCT00677443Phase 3
- NGR-hTNF Administered in Combination With a Standard Oxaliplatin Based Regimen in Patients With Metastatic Colorectal CancerCompletedNCT00675012Phase 2
- Study of GemOx and Vandetanib in Advanced Solid MalignancyCompletedNCT00660725Phase 1
- Study Of Advanced Gastrointestinal Malignancies And Other Solid TumorsCompletedNCT00660426Phase 1
- Phase 3 Study of Surgery Combined With Neoadjuvant Chemotherapy(XELOX) in Colorectal Cancer With Resectable Liver MetastasisStatus unknownNCT00630045Phase 3
- Gemcitabine With Or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Bladder CancerCompletedNCT00627432Phase 2
- Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal MalignanciesCompletedNCT00625092Phase 1
- Endometrial Cancer - LOHP Alone and With 5FUCompletedNCT00612495Phase 2
- Phase II Study of Oxaliplatine-Paclitaxel in Patients With Metastatic Germ Cell Tumor Refractory to CisplatinCompletedNCT00611962Phase 2
- Phase II Study of Oxaliplatin in Combination With 5-Fu in 1st Line Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT00611754Phase 2
- A Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non-Surgical or Advanced Metastatic Gastric CancerCompletedNCT00611507Phase 2
- Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Tumors That Did Not Respond to TreatmentCompletedNCT00610948Phase 1
- Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic CancerCompletedNCT00602602Phase 2
- Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric CancerSuspendedNCT00568529Phase 2
- Gemcitabine Plus Erlotinib Versus Erlotinib Plus Gemcitabine Plus Oxaliplatin, in Pancreatic CancerTerminatedNCT00564720Phase 2
- Phase II Study of Eloxatin+5-FU/LV in Patients With Unresectable Hepatocellular CarcinomaCompletedNCT00559455Phase 2
- Safety Study of Oxaliplatin and 5-fluorouracil Followed by FUDR for Unresectable Colorectal Liver MetastasesCompletedNCT00557557Phase 1
- Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck CancerTerminatedNCT00557206Phase 2
- Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal CancerCompletedNCT00556413Phase 2
- Leucovorin, Fluorouracil, Cetuximab, and Oxaliplatin in Treating Patients With Stage IV Colorectal Cancer and Liver Metastases That Cannot Be Removed by SurgeryCompletedNCT00544349Phase 2
- Capecitabine, Irinotecan, and Oxaliplatin in Treating Patients With Metastatic CancerStatus unknownNCT00544063Phase 1
- Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by SurgeryTerminatedNCT00541112Phase 2
- Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant MelanomaStatus unknownNCT00538005Phase 1/2
- A Phase I/II Trial of Docetaxel and Oxaliplatin in Patients With Advanced Gastric CancerCompletedNCT00533533Phase 1/2
- Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal CancerCompletedNCT00532909Phase 1
- A Phase I/II Trial of TS-1 and Oxaliplatin in Patients With Advanced Colorectal CancerCompletedNCT00531245Phase 1/2
- Phase II Trial of Oxaliplatin in Combination With S-1(SOX) in Patients With Recurrent or Metastatic Breast CancerCompletedNCT00527930Phase 2
- Phase I/II Study of SOL for Untreated Metastatic Colorectal CancerStatus unknownNCT00524706Phase 1/2
- Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric CarcinomaStatus unknownNCT00515190Phase 2
- Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by SurgeryStatus unknownNCT00513266Phase 2
- A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric CancerCompletedNCT00512681Phase 2
- Trial of Docetaxel, Oxaliplatin and Capecitabine (TEX) in Advanced or Metastatic Gastric CancerCompletedNCT00511446Phase 2
- Weekly Docetaxel Plus Cisplatin or Oxaliplatin for AGCStatus unknownNCT00510107Phase 2
- Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and AvastinCompletedNCT00507585Phase 1
- Phase II Study of Irinotecan,Oxaliplatin Plus TS-1 in Untreated Metastatic Colorectal CancerStatus unknownNCT00506571Phase 2
- A Phase I Study of S-1 Plus Irinotecan and Oxaliplatin in Advanced Gastrointestinal MalignancyStatus unknownNCT00506207Phase 1
- A Phase II Study of Gemcitabine With Oxaliplatin as First Line Chemotherapy in Advanced Biliary Tract CancerCompletedNCT00504192Phase 2
- FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal CancerCompletedNCT00501410Phase 1
- Phase I FOLFOX CombinationCompletedNCT00499850Phase 1
- Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With IrinotecanStatus unknownNCT00496704Phase 1/2
- Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal CarcinomatosisCompletedNCT00491855Phase 1
- Safety and Efficacy of Folfox4 + Weekly Cetuximab vs Folfox 4+Biweekly Cetuximab by Metastatic Colorectal CancerCompletedNCT00479752Phase 2
- Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) Versus Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma PatientsCompletedNCT00471965Phase 3
- Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by SurgeryStatus unknownNCT00471484Phase 2
- Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or LymphomaCompletedNCT00470405Phase 1
- Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic PatientsTerminatedNCT00470340Phase 3
- Intraperitoneal Hyperthermic Perfusion With Oxaliplatin in Treating Patients With Stage IV Peritoneal Cancer Due to Appendix Cancer or Colorectal CancerCompletedNCT00458809Phase 1
- Gemcitabine Plus Oxaliplatin in Advanced Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)Status unknownNCT00453115Phase 2
- Adjuvant Gemcitabine Plus Oxaliplatin Versus Gemcitabine Plus Cisplatin for Completely Resected Stage IB/II/IIIA NSCLCStatus unknownNCT00452881Phase 2
- Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00448838Not applicable
- Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck CancerCompletedNCT00448552Phase 2
- A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer.CompletedNCT00439426Phase 2
- Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal CancerStatus unknownNCT00438737Phase 2
- Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal CarcinomaCompletedNCT00436800Phase 2
- A Study of Xeloda (Capecitabine) as First-Line Chemotherapy in Patients With Advanced or Metastatic Gastric Cancer.CompletedNCT00436241Phase 2
- Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal CancerCompletedNCT00427713Phase 3
- Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal CancerStatus unknownNCT00425425Phase 1/2
- A Single Arm Trial of Oxaliplatin and 5FU With Concurrent Radiation in Patients With Metastatic Rectal CancerCompletedNCT00422864Phase 2
- Study of Neoadjuvant Chemotherapeutic Treatment (XELOX) Followed by Chemoradiotherapy (XELOX/RT) and Surgery Versus Chemoradiotherapy Followed by Surgery and Chemotherapy in Patients With High Risk Rectal CancerCompletedNCT00421824Phase 2
- AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck CancerStatus unknownNCT00415298Not applicable
- Capecitabine and Oxaliplatin Adjuvant Study in Stomach CancerCompletedNCT00411229Phase 3
- Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal CancerWithdrawnNCT00408772Phase 2
- Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the LiverStatus unknownNCT00408551Phase 2
- Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC)CompletedNCT00406302Phase 2
- Vinorelbine and Oxaliplatin (Vinox) With or Without Trastuzumab (Herceptin®) in Advanced Breast CarcinomaTerminatedNCT00403988Phase 2
- Evaluation of the Neoadjuvant Treatment With Oxaliplatin -UFT- Radiotherapy in Rectal CancerCompletedNCT00403624Phase 1/2
- TREE-2: Three Regimens of Eloxatin in Advanced Colorectal CancerCompletedNCT00399750Phase 2
- Adjuvant Xeloda Plus Eloxatin +/- Avastin After Radical Resection of Liver Metastasis of Colorectal CancerTerminatedNCT00394992Phase 3
- ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal CancerTerminatedNCT00385021Phase 2
- Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal CancerStatus unknownNCT00383695Phase 2
- Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-oesophageal JunctionCompletedNCT00374985Phase 1/2
- Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid TumorsCompletedNCT00374660Phase 1/2
- Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal CarcinomaStatus unknownNCT00363831Phase 2
- Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLCTerminatedNCT00356941Phase 1
- Capecitabine,Oxaliplatin & Erbitux Given Throughout Multi-Modal Therapy for Locally Advanced Rectal AdenocarcinomaTerminatedNCT00353457Phase 2
- Gemox as First and Second Line Therapy in Unknown Primary CancerCompletedNCT00353145Phase 2
- Etoposide, Oxaliplatin and Capecitabine in Advanced Hepatocellular Carcinoma (HCC)TerminatedNCT00351195Phase 2
- Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced CholangiocarcinomaCompletedNCT00350961Phase 1/2
- Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy With 5-Fluorouracil and Oxaliplatin Versus 5-Fluorouracil Alone in Rectal CancerCompletedNCT00349076Phase 3
- Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic CancerStatus unknownNCT00323583Phase 2
- Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung CancerTerminatedNCT00316433Phase 2
- Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic CancerTerminatedNCT00307723Phase 1/2
- Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00305786Phase 2
- Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By SurgeryCompletedNCT00304135Phase 2/3
- Preoperative Combined Radiochemotherapy for Patients With Rectal CarcinomaCompletedNCT00297141Phase 2
- Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal CancerTerminatedNCT00296062Phase 1
- Combination Chemotherapy in Treating Young Patients With Advanced Solid TumorsCompletedNCT00281944Phase 1
- Oxaliplatin in Unresectable Hepatocellular CarcinomaCompletedNCT00280618Phase 2
- Oxaliplatin and 5-FU Based Preoperative ChemoradiationCompletedNCT00278694Phase 2
- MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon CancerCompletedNCT00275210Phase 3
- Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By SurgeryStatus unknownNCT00275119Phase 2
- Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal CancerStatus unknownNCT00274885Phase 4
- Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryStatus unknownNCT00274872Phase 2/3
- Gemcitabine and Oxaliplatin in Treating Patients With Metastatic CancerStatus unknownNCT00274859Phase 2
- Efficacy Study of GEMOX Combination and Vinorelbine in NSCL PatientsCompletedNCT00271271Phase 2
- Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic CancerStatus unknownNCT00268411Phase 3
- Combination Chemotherapy in Treating Patients With Colorectal Cancer and Resectable MetastasesCompletedNCT00268398Phase 3
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Recurrent Metastatic Colorectal CancerCompletedNCT00268333Phase 2
- Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung CancerTerminatedNCT00268151Phase 1